Physician profile
Dorothy C Serna
NPI 1922096957
$1,687.01
in general payments reported to CMS, 2019-2025
15 companies · $500 in 2025
The $500 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $36.13 · 2022: $187 · 2023: $394 · 2024: $569 · 2025: $500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,464.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $411.08 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $336.19 | 2021-2025 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $233.24 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $160.12 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $106.97 | 2023-2024 | Prolia, Evenity |
| Dexcom, INC. | $89.48 | 2023-2025 | Dexcom G6 Transmitter |
| Ibsa Pharma INC. | $73.61 | 2022-2024 | Licart, Tirosint |
| Bayer Healthcare Pharmaceuticals INC. | $65.56 | 2022-2023 | |
| Pfizer INC. | $54.60 | 2024-2025 | |
| Intuitive Surgical, INC. | $48.68 | 2024 | |
| Paratek Pharmaceuticals, INC. | $33.04 | 2024 | Nuzyra |
| Echosens North America, INC. | $23.65 | 2024 | Fibroscan |
| Exact Sciences Corporation | $21.61 | 2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $14.75 | 2023 | Shingrix, Arexvy |
| Myriad Genetic Laboratories, INC. | $14.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dorothy Serna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.